Skip to main content

Teva Held Responsible For Fueling Opioid Crisis In NY

Teva Held Responsible For Fueling Opioid Crisis In NY

Teva Held Responsible For Fueling Opioid Crisis In NY

Introduction

Teva Pharmaceuticals has been held responsible for fueling the opioid crisis in the New York state as per the ruling by a New York jury in Suffolk County State Supreme Court.

As per the jury's ruling, Teva is responsible for creating a public nuisance in Suffolk and Nassau counties by oversupplying opioids. It is the second verdict from the nationwide opioid crisis litigation.

Another trial would be held to decide upon the settlement amount that Teva requires to pay along with different opioid manufacturers and distributors who will pay $1.5 billion as declared by the state's attorney general. Teva has strongly opposed the agreement and has indicated to appeal against it.

As per the California ruling of last month, Teva did not make any false statements in the marketing of opioids and did not cause a public nuisance in Orange County, Los Angeles County, Santa Clara County and the City of Oakland.

Last month, judgment against a pharmaceutical manufacturer that ruled the public nuisance law does extend to the marketing and selling of prescription opioids was overturned by the Oklahoma Supreme Court.

The New York Attorney General Letitia James filed a lawsuit against opioid manufacturers in March 2019 for fueling the opioid epidemic throughout the nation. The defendants in the lawsuit include Mallinckrodt LLC and its affiliates, Janssen Pharmaceuticals and its affiliates, Endo Health Solutions and its affiliates, Allergan Finance, LLC and its affiliates and Purdue Pharma and its affiliates.

Since 1999, the opioid crisis has resulted in many deaths in the U.S. The opioid crisis was caused because of the opioid oversupply of major drug distributors for making profits.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.